Related Experiment Video
Updated: Jul 11, 2026
08:30
Chondrogenic Differentiation Induction of Adipose-derived Stem Cells by Centrifugal Gravity
Published on: February 24, 2017
Src kinase inhibition promotes the chondrocyte phenotype
Laura Bursell1, Anita Woods, Claudine G James
1Department of Physiology and Pharmacology, Canadian Institutes of Health Research Group in Skeletal Development and Remodeling, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada, N6A 5C1.
Arthritis Research & Therapy
|October 12, 2007
Summary
Inhibiting Src kinase activity with PP2 promotes chondrocyte differentiation and cartilage development. This finding offers potential therapeutic strategies for osteoarthritis and cartilage tissue engineering.
Area of Science:
- Cell Biology
- Biochemistry
- Skeletal Development
Background:
- Chondrocyte differentiation is crucial for skeletal development and cartilage maintenance.
- Intracellular pathways regulating chondrocyte phenotype are not fully understood.
- Modulating chondrocyte behavior in vitro and in vivo remains challenging.
Purpose of the Study:
- To investigate the role of Src family kinases in regulating chondrocyte phenotype.
- To explore the effects of Src kinase inhibition on chondrocyte differentiation.
- To assess the potential of Src kinase inhibitors in cartilage tissue engineering and disease treatment.
Main Methods:
- Examined Src family kinase Lyn expression in ATDC5 cells and embryonic mouse chondrocytes.
- Utilized the Src kinase inhibitor PP2 (4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]pyrimidine).
- Assessed chondrocyte differentiation markers, morphology, and signaling pathways.
Main Results:
- PP2 treatment reduced primary mouse chondrocyte numbers.
- PP2 enhanced expression of early (Sox9, collagen type II, aggrecan) and late (collagen type X, Indian hedgehog) chondrogenic markers.
- PP2 reversed chondrocyte dedifferentiation, induced rounding, and reduced focal adhesion kinase phosphorylation.
Conclusions:
- Src kinase inhibitor PP2 promotes chondrogenic gene expression and morphology in vitro.
- Blocking Src activity may be beneficial for cartilage tissue engineering.
- Targeting Src activity could help maintain chondrocyte phenotype in osteoarthritis.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...